These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 29602546)
1. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data. Wu H; Zhang J Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546 [TBL] [Abstract][Full Text] [Related]
2. L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA). Dellinger TH; Smith DD; Ouyang C; Warden CD; Williams JC; Han ES Gynecol Oncol; 2016 May; 141(2):336-340. PubMed ID: 26861585 [TBL] [Abstract][Full Text] [Related]
3. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. Zhang Q; Xia T; Qi C; Du J; Ye C BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454 [TBL] [Abstract][Full Text] [Related]
4. Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative. Edmondson RJ; Crosbie EJ; Nickkho-Amiry M; Kaufmann A; Stelloo E; Nijman HW; Leary A; Auguste A; Mileshkin L; Pollock P; MacKay HJ; Powell ME; Bosse T; Creutzberg CL; Kitchener HC Gynecol Oncol; 2017 Aug; 146(2):327-333. PubMed ID: 28511869 [TBL] [Abstract][Full Text] [Related]
5. Correlation between transcription factor activator protein-2β (TFAP-2β) and endometrial carcinoma. Cui P; Shi K; Cui HX; Hao LY; Su Y; Li PL Eur J Gynaecol Oncol; 2015; 36(3):268-73. PubMed ID: 26189251 [TBL] [Abstract][Full Text] [Related]
6. CDCA8 as an independent predictor for a poor prognosis in liver cancer. Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433 [TBL] [Abstract][Full Text] [Related]
7. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics. Qiu X; Gao Z; Shao J; Li H Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study. Zhu J; Wen H; Bi R; Wu X J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439 [TBL] [Abstract][Full Text] [Related]
10. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell. Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975 [TBL] [Abstract][Full Text] [Related]
11. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database. Zelong Y; Han Y; Ting G; Yifei W; Kun H; Haoran H; Yong C Medicine (Baltimore); 2021 Aug; 100(31):e26623. PubMed ID: 34397798 [TBL] [Abstract][Full Text] [Related]
13. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients. Jiang P; Sun W; Shen N; Huang X; Fu S BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095 [TBL] [Abstract][Full Text] [Related]
14. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data. Zeng Z; Cao Z; Zhang E; Huang H; Tang Y Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796 [TBL] [Abstract][Full Text] [Related]
15. p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review. Lee EJ; Kim TJ; Kim DS; Choi CH; Lee JW; Lee JH; Bae DS; Kim BG Gynecol Oncol; 2010 Mar; 116(3):533-8. PubMed ID: 20006376 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis. Fu Y; Sun S; Man X; Kong C PeerJ; 2019; 7():e7854. PubMed ID: 31592165 [TBL] [Abstract][Full Text] [Related]
17. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data. Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589 [TBL] [Abstract][Full Text] [Related]
18. LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data. Kim SI; Lee JW; Lee N; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS BMC Cancer; 2018 May; 18(1):494. PubMed ID: 29716549 [TBL] [Abstract][Full Text] [Related]
19. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data. Zeng Z; Cao Z; Tang Y BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417 [TBL] [Abstract][Full Text] [Related]
20. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer. Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]